HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,838 | -38.4% | 18,289 | -30.7% | 0.00% | – |
| Q2 2023 | $30,593 | -99.4% | 26,373 | -99.2% | 0.00% | -100.0% |
| Q1 2023 | $5,039,344 | -43.4% | 3,337,314 | -6.3% | 0.06% | -46.2% |
| Q4 2022 | $8,902,120 | -62.3% | 3,560,848 | -36.4% | 0.11% | -63.4% |
| Q3 2022 | $23,636,000 | +27.4% | 5,601,107 | -15.8% | 0.29% | +36.8% |
| Q2 2022 | $18,551,000 | -50.8% | 6,649,172 | +1.0% | 0.21% | -35.8% |
| Q1 2022 | $37,675,000 | -35.6% | 6,586,502 | +2.8% | 0.33% | -29.6% |
| Q4 2021 | $58,486,000 | -14.8% | 6,405,865 | -0.2% | 0.47% | -12.7% |
| Q3 2021 | $68,644,000 | -25.1% | 6,421,335 | +8.8% | 0.54% | -22.2% |
| Q2 2021 | $91,630,000 | +0.4% | 5,903,968 | +4.8% | 0.69% | +1.0% |
| Q1 2021 | $91,279,000 | -19.6% | 5,631,016 | +5.0% | 0.68% | -22.3% |
| Q4 2020 | $113,478,000 | +51.3% | 5,361,611 | +6.0% | 0.88% | +22.9% |
| Q3 2020 | $74,982,000 | -1.4% | 5,059,526 | -2.2% | 0.72% | -9.0% |
| Q2 2020 | $76,072,000 | +46.1% | 5,171,424 | +16.6% | 0.79% | +14.9% |
| Q1 2020 | $52,064,000 | -46.1% | 4,434,787 | +7.9% | 0.68% | -20.4% |
| Q4 2019 | $96,553,000 | +25.2% | 4,108,628 | -1.4% | 0.86% | +11.7% |
| Q3 2019 | $77,094,000 | +6.2% | 4,167,250 | +6.7% | 0.77% | +10.2% |
| Q2 2019 | $72,619,000 | +11.3% | 3,906,362 | +46.4% | 0.70% | +13.5% |
| Q1 2019 | $65,222,000 | +13.0% | 2,668,643 | +19.9% | 0.62% | +1.5% |
| Q4 2018 | $57,718,000 | -10.0% | 2,225,050 | +9.8% | 0.61% | +12.8% |
| Q3 2018 | $64,127,000 | -25.6% | 2,026,141 | -8.7% | 0.54% | -32.1% |
| Q2 2018 | $86,184,000 | +31.9% | 2,218,376 | -6.3% | 0.79% | +21.1% |
| Q1 2018 | $65,355,000 | +330.8% | 2,367,922 | +182.5% | 0.65% | +324.0% |
| Q4 2017 | $15,170,000 | +49.2% | 838,117 | +33.1% | 0.15% | +32.8% |
| Q3 2017 | $10,168,000 | +33.5% | 629,569 | +14.5% | 0.12% | +23.4% |
| Q2 2017 | $7,617,000 | -2.4% | 549,960 | +5.7% | 0.09% | -11.3% |
| Q1 2017 | $7,803,000 | +20434.2% | 520,169 | +23205.1% | 0.11% | +10500.0% |
| Q3 2016 | $38,000 | – | 2,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |